|Day Low/High||97.64 / 99.39|
|52 Wk Low/High||78.97 / 104.82|
Honeywell fits what we are looking to buy in this market -- quality names that reported strong quarters and are now trading at a discount.
Jim discusses our trades from this morning, earnings from Danaher and Nucor, and the JPMorgan-Berkshire Hathaway-Amazon healthcare deal.
Quarterly numbers driven by growth in life sciences and diagnostics businesses.
You might actually be grateful that stocks took one on the jaw on Monday.
The Dow is looking at its second consecutive triple-digit decline on Tuesday, Thomson Reuters confirms it's in talks to sell a stake in its financial and risk business, and Jamie Dimon says he'll stay at JPMorgan Chase for five more years.
Jim discusses GE, Comcast, Illinois Tool Works, and Abbott Labs, all of which reported earnings Wednesday morning.
Could Danaher be interested in GE's Life Sciences business?
Jim discusses our outlook on Allergan, JPMorgan's investment plan, Microsoft, Constellation Brands, and more!
In today's video, Jim discusses the government shutdown, an Eli Lilly downgrade, Schlumberger after Friday's earnings, and several other market-related topics.
It's hard to understand the magnitude of the change.
Jim discusses yesterday's market reversal and what to look for, GE news, Apple, healthcare and the financials.
Jim discusses GE, Citigroup's earnings, Facebook's update to its news feed update, and our price target for Activision.
The latest consumer and producer price indexes are good news for Apple and other portfolio names with large exposure to China.
In today's video, Jim discusses our newest initiation in Constellation Brands, Danaher at the JP Morgan Healthcare conference, and energy stocks.
The CEO of the diversified machinery company says its core growth as well as earnings per share will top its guidance range when it releases the numbers at the end of the month.
You can make a case to buy any of the stocks of the companies at ICR.
Investors are regaining interest in the stock due to the positive risk/reward.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.